94 related articles for article (PubMed ID: 17934909)
1. Neurotrophic factor receptor RET: structure, cell biology, and inherited diseases.
Runeberg-Roos P; Saarma M
Ann Med; 2007; 39(8):572-80. PubMed ID: 17934909
[TBL] [Abstract][Full Text] [Related]
2. Glial cell line-derived neurotrophic factors (GFLs) and small molecules targeting RET receptor for the treatment of pain and Parkinson's disease.
Mahato AK; Sidorova YA
Cell Tissue Res; 2020 Oct; 382(1):147-160. PubMed ID: 32556722
[TBL] [Abstract][Full Text] [Related]
3. Analysis of DOK-6 function in downstream signaling of RET in human neuroblastoma cells.
Kurotsuchi A; Murakumo Y; Jijiwa M; Kurokawa K; Itoh Y; Kodama Y; Kato T; Enomoto A; Asai N; Terasaki H; Takahashi M
Cancer Sci; 2010 May; 101(5):1147-55. PubMed ID: 20210798
[TBL] [Abstract][Full Text] [Related]
4. RET signalling controls gut motility.
Ray K
Nat Rev Gastroenterol Hepatol; 2024 Feb; 21(2):71. PubMed ID: 38066101
[No Abstract] [Full Text] [Related]
5. Structural studies of GDNF family ligands with their receptors-Insights into ligand recognition and activation of receptor tyrosine kinase RET.
Wang X
Biochim Biophys Acta; 2013 Oct; 1834(10):2205-12. PubMed ID: 23085183
[TBL] [Abstract][Full Text] [Related]
6. Neuroprotection by GDNF in the ischemic brain.
Duarte EP; Curcio M; Canzoniero LM; Duarte CB
Growth Factors; 2012 Aug; 30(4):242-57. PubMed ID: 22670840
[TBL] [Abstract][Full Text] [Related]
7. The role of GDNF family ligand signalling in the differentiation of sympathetic and dorsal root ganglion neurons.
Ernsberger U
Cell Tissue Res; 2008 Sep; 333(3):353-71. PubMed ID: 18629541
[TBL] [Abstract][Full Text] [Related]
8. Targeting the RET tyrosine kinase in neuroblastoma: A review and application of a novel selective drug design strategy.
Steen EA; Basilaia M; Kim W; Getz T; Gustafson JL; Zage PE
Biochem Pharmacol; 2023 Oct; 216():115751. PubMed ID: 37595672
[TBL] [Abstract][Full Text] [Related]
9. The high expression of glial cell line-derived neurotrophic factor receptor alpha Ⅱ (
Yang S; Li J; Cai X
Heliyon; 2023 Jul; 9(7):e18291. PubMed ID: 37519699
[TBL] [Abstract][Full Text] [Related]
10. A Familial Case of Multiple Endocrine Neoplasia 2A: From Morphology to Genetic Alterations Penetration in Three Generations of a Family.
Chen L; Zhang JX; Liu DG; Liu HG
Diagnostics (Basel); 2023 Mar; 13(5):. PubMed ID: 36900098
[TBL] [Abstract][Full Text] [Related]
11. Glial-derived neurotrophic factor in human airway smooth muscle.
Bhallamudi S; Roos BB; Teske JJ; Wicher SA; McConico A; M Pabelick C; Sathish V; Prakash YS
J Cell Physiol; 2021 Dec; 236(12):8184-8196. PubMed ID: 34170009
[TBL] [Abstract][Full Text] [Related]
12. Obligatory Activation of SRC and JNK by GDNF for Survival and Axonal Outgrowth of Postnatal Intestinal Neurons.
Blennerhassett MG; Lourenssen SR
Cell Mol Neurobiol; 2022 Jul; 42(5):1569-1583. PubMed ID: 33544273
[TBL] [Abstract][Full Text] [Related]
13. RET Receptor Tyrosine Kinase: Role in Neurodegeneration, Obesity, and Cancer.
Mahato AK; Sidorova YA
Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 32993133
[TBL] [Abstract][Full Text] [Related]
14. Cryo-EM structure of the activated RET signaling complex reveals the importance of its cysteine-rich domain.
Bigalke JM; Aibara S; Roth R; Dahl G; Gordon E; Dorbéus S; Amunts A; Sandmark J
Sci Adv; 2019 Jul; 5(7):eaau4202. PubMed ID: 31392261
[TBL] [Abstract][Full Text] [Related]
15. RET rearrangements are actionable alterations in breast cancer.
Paratala BS; Chung JH; Williams CB; Yilmazel B; Petrosky W; Williams K; Schrock AB; Gay LM; Lee E; Dolfi SC; Pham K; Lin S; Yao M; Kulkarni A; DiClemente F; Liu C; Rodriguez-Rodriguez L; Ganesan S; Ross JS; Ali SM; Leyland-Jones B; Hirshfield KM
Nat Commun; 2018 Nov; 9(1):4821. PubMed ID: 30446652
[TBL] [Abstract][Full Text] [Related]
16. Recent advances in the biology and therapy of medullary thyroid carcinoma.
Nelkin B
F1000Res; 2017; 6():2184. PubMed ID: 29333262
[TBL] [Abstract][Full Text] [Related]
17. Neurturin overexpression in dopaminergic neurons induces presynaptic and postsynaptic structural changes in rats with chronic 6-hydroxydopamine lesion.
Reyes-Corona D; Vázquez-Hernández N; Escobedo L; Orozco-Barrios CE; Ayala-Davila J; Moreno MG; Amaro-Lara ME; Flores-Martinez YM; Espadas-Alvarez AJ; Fernandez-Parrilla MA; Gonzalez-Barrios JA; Gutierrez-Castillo ME; González-Burgos I; Martinez-Fong D
PLoS One; 2017; 12(11):e0188239. PubMed ID: 29176874
[TBL] [Abstract][Full Text] [Related]
18. A Novel Small Molecule GDNF Receptor RET Agonist, BT13, Promotes Neurite Growth from Sensory Neurons
Sidorova YA; Bespalov MM; Wong AW; Kambur O; Jokinen V; Lilius TO; Suleymanova I; Karelson G; Rauhala PV; Karelson M; Osborne PB; Keast JR; Kalso EA; Saarma M
Front Pharmacol; 2017; 8():365. PubMed ID: 28680400
[TBL] [Abstract][Full Text] [Related]
19. Combined kinase inhibitors of MEK1/2 and either PI3K or PDGFR are efficacious in intracranial triple-negative breast cancer.
Van Swearingen AED; Sambade MJ; Siegel MB; Sud S; McNeill RS; Bevill SM; Chen X; Bash RE; Mounsey L; Golitz BT; Santos C; Deal A; Parker JS; Rashid N; Miller CR; Johnson GL; Anders CK
Neuro Oncol; 2017 Oct; 19(11):1481-1493. PubMed ID: 28486691
[TBL] [Abstract][Full Text] [Related]
20. Ret function in muscle stem cells points to tyrosine kinase inhibitor therapy for facioscapulohumeral muscular dystrophy.
Moyle LA; Blanc E; Jaka O; Prueller J; Banerji CR; Tedesco FS; Harridge SD; Knight RD; Zammit PS
Elife; 2016 Nov; 5():. PubMed ID: 27841748
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
